Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone tapering methods in methadone-poisoned non-addicted adults
IRCT20220305054196N1Phase 3Completed
- Sponsor
- Korea Institute of Toxicology
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of naloxone in methadone intoxication (2 arms), sponsored by Korea Institute of Toxicology. Primary endpoints: Naloxone loading rate, Number of doses of naloxone received and 2 more. Started Apr 2022; status: completed.
02
Drugs
naloxone
03
Conditions
methadone intoxication
Beyond the preview
Go deeper on IRCT20220305054196N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220305054196N1.